Go to Content

CellFiber Co., Ltd.

CellFiber Co., Ltd. logo

As of January 2024

City Year of Establishment Founder
Tokyo, Japan 2015 Aki Adachi, Shoji Takeuchi, Teru Okitsu, Hiroaki Onoe
Partner VC Latest round of Fundraising Valuation
JAFCO Group Co., Ltd. Series A JPY 2,300 million

Program name

Deep-Tech Startups Support Program

Research theme

GMP manufacturing of cells with CellFiberTM Technology

Business Plan

While cell therapy has grown in popularity and effectiveness, the manufacturing process still relies heavily on manual labor.

Technology is a technique for encapsulating and culturing cells in hollow hydrogel tubes, which should facilitate large-scale production of cellular products.

Under this project scheme, we aim to implement this technology in GMP environment and confirm effective production of cellular products.

Research Outline

We plan to achieve below items by collaborating with business partners in and out of Japan.

  1. Develop GMP manufacturing process of CellFiberTM
  2. Optimize GMP manufacturing process of Investigational New Drug with CellFiberTM technology
  3. Comply with necessary regulations including GMP for drug cellular products.
  4. EA, Single-use Kit and Reagent shall comply with GMP
Phase Business Area/Field Research Period Research Grant Amount
PCA Healthcare 2023~2024 FY JPY 394 million

Last Updated : April 30, 2024